SCHEMBL9590350

SCHEMBL9590350

CCCCc1nn(-c2ccccc2Cl)c(=O)n1Cc1ccc(OC(c2nnn[nH]2)c2ccccc2Cl)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9592185 0.95 — —
SCHEMBL9590206 0.93 — —
SCHEMBL9590868 0.92 — —
SCHEMBL9590540 0.89 AGTR1 (0.52) —
SCHEMBL9592870 0.88 AGTR1 (0.48) —
SCHEMBL9592428 0.87 AGTR1 (0.54) —
SCHEMBL9592501 0.85 AGTR1 (0.48) —
SCHEMBL9592978 0.85 EDNRA (0.47) —
SCHEMBL9593124 0.85 AGTR1 (0.44) —
SCHEMBL9591826 0.85 AGTR1 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5264439-A Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element MERCK & CO., INC. (US) 1993-11-23 — — US disclosed
Send feedback